Clinical Trial Update: Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC [NA]

View source ↗

Summary

This document reports that a real-world, first-line trial of sugemalimab in combination with chemotherapy for advanced non-small cell lung cancer is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sugemalimab (sugemalimab)

Snippet

Sponsor: Peking Union Medical College | Conditions: NSCLC | NA | Status: RECRUITING